Skip to content
You can now search across every topic, entity and event.What's new
TidalSense
OrganisationGB

TidalSense

Cambridge healthtech company that raised £14.2m in July 2026.

Last refreshed: 31 July 2026 · Appears in 1 active topic

Key Question

TidalSense raised £14.2m from four investors with no named lead; who actually priced the round?

Timeline for TidalSense

#13 24 Jul

Raised £14.2m from a four-investor syndicate

UK Startups and Innovation: TidalSense takes £14.2m with no lead
View full timeline →

Background

TidalSense, a Cambridge respiratory-diagnostics company, raised £14.2 million on 24 July 2026 from a four-investor syndicate with no disclosed lead: Cross-Border Impact Ventures, BGF, Airstream Capital and Foresight Group .

Formerly Cambridge Respiratory Innovations, TidalSense was founded in 2013 and builds N-Tidal, a handheld sensor that diagnoses COPD from 75 seconds of normal breathing rather than the forceful exhalation spirometry requires; the software received an EU CE mark in March 2025.

A lead investor normally sets a round's price, negotiates terms and takes a board seat. TidalSense's syndicate has none, which fits a company whose principal risk sits with regulators and health-service procurement rather than the open market .

Common Questions
What is TidalSense?
TidalSense is a Cambridge healthtech company that raised £14.2m on 24 July 2026 from a four-investor syndicate.Source: UKTN
Who led TidalSense's £14.2m round?
No investor was disclosed as leading TidalSense's round. The four backers were Cross-Border Impact Ventures, BGF, Airstream Capital and Foresight Group.Source: UKTN
Why does it matter that TidalSense's round had no lead investor?
A lead investor normally sets the price, negotiates terms and takes a board seat. A syndicate with no lead means the round's valuation has no single public backer standing behind it.Source: Lowdown
When did TidalSense raise its £14.2m round?
TidalSense raised £14.2m on Friday 24 July 2026.Source: UKTN